1-4 of 4
Authors: Jolanta M Siller-Matula
Journal Article
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy: A clinical consensus statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care (ACVC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy and the European Association for Haemophilia and Allied Disorders (EAHAD)
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Pages 275–289, https://doi.org/10.1093/ehjcvp/pvaf006
Published: 26 March 2025
Journal Article
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 2, March 2021, Pages 125–140, https://doi.org/10.1093/ehjcvp/pvaa009
Published: 12 February 2020
Journal Article
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 4, July 2020, Pages 203–210, https://doi.org/10.1093/ehjcvp/pvz045
Published: 03 September 2019
Journal Article
Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 3, Issue 4, October 2017, Pages 221–234, https://doi.org/10.1093/ehjcvp/pvw044
Published: 15 February 2017
